Want to help keep health bills down? Maybe it's time to go shopping for that next colonoscopy.
Millions of Americans undergo the screening procedure for colon cancer each year, and costs can range from $500 to more than $8,000.
But recent experiences in California suggest that insurers and large employers could save a bundle by picking a midrange price and letting patients put the sum toward a colonoscopy from the health care provider of their choice. The catch is, patients would have to pay the difference if they pick a center that charges more than what's called the "reference price" for the procedure.
"It leads to pretty substantial changes in consumer behavior," said Christopher Whaley, a research economist at the University of California-Berkeley. "And it leads to a pretty large savings."
Whaley and colleagues have projected that such a program could shave $107, or about 7 percent, from the cost of each colonoscopy in Minneapolis, while saving $95 million per year nationally just for three large health insurance companies included in a new study.
The research published this week is the latest example of how health economists are using price data from a group of large national health insurers, including Minnetonka-based UnitedHealthcare, to study potential remedies to tame health care inflation.
Even so, not everyone is convinced about the potential for reference-based pricing, which the California Public Employees' Retirement System (CalPERS) has used for several years for colonoscopies, hip replacements and knee replacements.
In Minnesota, state law bars health care providers from billing patients for the balance of what a health plan won't pay, said Matt Anderson, senior vice president of policy and strategy at the Minnesota Hospital Association. So a hospital or surgery center would either have to match the reference price or drop out of the health plan's network. "It could limit access to care for some Minnesotans," Anderson said.